The concern is that the blood sugar-lowering effects of both could be additive , increasing the risk of hypoglycemia (low blood sugar)
Gastric emptying scintigraphy, wireless capsule motility testing, or breath testing quantifies your baseline delay severity
Participants were treated with exenatide for 48 weeks
In Search of a Physiological Function for L-Ergothioneine--II
Furthermore, GLP-1RAs have been shown to positively influence body weight and metabolic control, which are critical factors in managing patients at risk of developing HCC (Wang et al., 2024)
The association between GLP-1RA use and a decreased risk of glaucoma, along with its potential implication for other neurodegenerative diseases, offers a promising avenue for targeted treatment as further research findings emerge